Xiaosong Chen
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 99
- HER2/EGFR in Cancer Research 44
- Cancer Treatment and Pharmacology 16
- Cancer Cells and Metastasis 14
- Cancer Risks and Factors 14
- Cancer Immunotherapy and Biomarkers 11
-
- Breast Cancer Treatment Studies 74
- Co-authors
- Kunwei Shen (127 shared papers)Ou Huang (57 shared papers)Jiayi Wu (57 shared papers)Xiaochun Fei (33 shared papers)Qing Qu (6 shared papers)Weiguo Chen (52 shared papers)Shuning Ding (8 shared papers)Yan Mao (10 shared papers)
- Journals
- Frontiers in Oncology (14 papers)Breast Cancer Research and Treatment (7 papers)Scientific Reports (6 papers)BMC Cancer (6 papers)Journal of Cancer (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaosong Chen
155 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 1.3k
- Oncology 1.5k
- Pathology and Forensic Medicine 469
- Radiology, Nuclear Medicine and Imaging 588
- Hepatology 167
Countries citing papers authored by Xiaosong Chen
This map shows the geographic impact of Xiaosong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Chen more than expected).
Fields of papers citing papers by Xiaosong Chen
This network shows the impact of papers produced by Xiaosong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Chen. The network helps show where Xiaosong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaosong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 202 | |
| 2 | 2015 | 192 | |
| 3 | 2014 | 174 | |
| 4 | 2020 | 166 | |
| 5 | 2010 | 115 | |
| 6 | 2017 | 106 | |
| 7 | 2013 | 95 | |
| 8 | 2012 | 90 | |
| 9 | 2012 | 73 | |
| 10 | 2021 | 65 | |
| 11 | 2021 | 60 | |
| 12 | 2013 | 56 | |
| 13 | 2016 | 53 | |
| 14 | 2013 | 50 | |
| 15 | 2016 | 44 | |
| 16 | 2020 | 43 | |
| 17 | 2015 | 42 | |
| 18 | 2021 | 41 | |
| 19 | 2016 | 41 | |
| 20 | 2022 | 37 |
About Xiaosong Chen
Xiaosong Chen is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 163 papers that have together received 3.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (74 papers), HER2/EGFR in Cancer Research (44 papers), Breast Lesions and Carcinomas (32 papers), Cancer Treatment and Pharmacology (16 papers), Advanced Breast Cancer Therapies (16 papers), Cancer Cells and Metastasis (14 papers), Cancer Risks and Factors (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.5k citations), Pathology and Forensic Medicine (469 citations), Radiology, Nuclear Medicine and Imaging (588 citations) and Hepatology (167 citations). Xiaosong Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Kunwei Shen, Ou Huang, Jiayi Wu, Xiaochun Fei, Qing Qu, Weiguo Chen, Shuning Ding, Yan Mao, Yafen Li and Jianrong He. Their work appears in journals such as Frontiers in Oncology, Breast Cancer Research and Treatment, Scientific Reports, BMC Cancer and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.